1. Home
  2. AGCO vs CDTX Comparison

AGCO vs CDTX Comparison

Compare AGCO & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$106.31

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo Cidara Therapeutics Inc.

CDTX

Cidara Therapeutics Inc.

HOLD

Current Price

$220.73

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
CDTX
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
6.9B
IPO Year
1992
2015

Fundamental Metrics

Financial Performance
Metric
AGCO
CDTX
Price
$106.31
$220.73
Analyst Decision
Hold
Buy
Analyst Count
10
12
Target Price
$112.00
$128.75
AVG Volume (30 Days)
843.3K
1.1M
Earning Date
02-05-2026
11-06-2025
Dividend Yield
3.46%
N/A
EPS Growth
121.88
N/A
EPS
5.02
N/A
Revenue
$10,049,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.17
N/A
P/E Ratio
$21.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$73.79
$15.22
52 Week High
$121.16
$221.20

Technical Indicators

Market Signals
Indicator
AGCO
CDTX
Relative Strength Index (RSI) 49.67 85.84
Support Level $102.21 $219.91
Resistance Level $109.11 $220.78
Average True Range (ATR) 3.21 0.71
MACD 0.08 -4.33
Stochastic Oscillator 44.91 70.62

Price Performance

Historical Comparison
AGCO
CDTX

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: